What we're reading, September 26, 2016: the obesity rate in America has been rising steadily, but the health system is ill equipped to treat these patients; the pros and cons of mail-order medications; and barring recipients of federal funding from preventing money from going to Planned Parenthood.
The obesity rate in America has been growing steadily for 2 decades, but the health system remains ill equipped to treat overweight and obese patients. According to The New York Times, a lack of machines built big enough to service obese patients, drug doses that aren’t calibrated properly, and other difficulties mean obese patients often receive worse care than patients who are not overweight or obese. In addition, most doctors are reluctant to look beyond weight when it comes to diagnosing health problems.
Mail-order medications may have a number of benefits, but getting prescriptions through the mail may not be well suited to all medications. Convenience is a driver for mail-order prescriptions, but savings are not guaranteed and not all medications should be mail ordered, according to The Washington Post. Mail programs are ideal for drugs used on an ongoing basis that will be taken at a set dosage for a long time. However, issues can arise when a dosage changes, generics may not always be available right away, and certain drugs have shipping restrictions.
A proposal from the Obama administration would prevent recipients of federal family planning grants from preventing the money from going to Planned Parenthood. The Associated Press reported that the changes to the Title X grant program would bar recipients from placing their own eligibility restrictions on where the money can go. The program was designed to provide contraception services, screening and treatment for sexually transmitted diseases, and other services to low-income patients. It only pays for abortion in cases of rape, incest, or if the mother’s life is in danger.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More